Skip to main content

Table 1 Patient demographics and characteristics

From: Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Characteristics

STEP I (N = 12,244)

STEP II (N = 2023)

Sex, n

12,244

2023

  (Male, %) (Female, %)

6105, 49.86) (6139, 50.14)

(1001, 49.48) (1022, 50.52)

Age (Year)

n (Mean ± SD)

12,244 (61.4 ± 11.2)

2023 (61.7 ± 11.6)

Height (cm)

n (Mean ± SD)

12,163 (162.4 ± 8.9)

2013 (162.3 ± 9.0)

Weight (kg)

n (Mean ± SD)

12,169 (65.7 ± 11.4)

2014 (65.6 ± 11.4)

BMI (kg/m2)

n (Mean ± SD)

12,162 (24.8 ± 3.2)

2013 (24.8 ± 3.1)

Region of residence, n

12,152

1998

 Metropolitan area, n (%)

6560 (54.0)

1139 (57.0)

 Micropolitan area, n (%)

4466 (36.8)

724 (36.2)

 Small Town, n (%)

1126 (9.3)

135 (6.8)

Education Level, n

11,919

1961

  < High School graduate, n (%)

5304 (44.5)

882 (45.0)

  ≥ High School graduate, n (%)

6615 (55.5)

1079 (55.0)

Income level, n

11,953

1967

  < $3500 per month, n (%)

7159 (59.9)

1220 (62.0)

  ≥ $3500 per month, n (%)

3520 (29.5)

502 (25.5)

 Others

1274 (10.7)

245 (12.5)

Drinking, n

12,243

2023

 Non-drinker, n (%)

7646 (62.5)

1298 (64.2)

 Drinker, n (%)

4597 (37.6)

725 (35.8)

Smoking, n

12,243

2023

 Non-smoker, n (%)

9273 (75.7)

1547 (76.5)

 Former Smoker, n (%)

1195 (9.8

158 (7.8)

 Smoker, n (%)

1775 (14.5)

318 (15.7)

Exercise, n

12,230

2021

 Non-regularly, n (%)

6933 (56.7)

1245 (61.6)

 Regularly, n (%)

5297 (43.3)

776 (38.4)

Home blood pressure monitor, n

12,239

2020

 Without Possession, n (%)

8597 (70.2)

1458 (72.2)

 In Possession, n (%)

3642 (29.8)

562 (27.8)

Blood pressure monitoring at home, n

3638

561

 Not Measure, n (%)

969 (26.6)

149 (26.6)

 Measure, n (%)

2669 (73.4)

412 (73.4)

Family history of hypertension, n

12,207

2010

 YES, n (%)

5775 (47.3)

930 (46.3)

 NO, n (%)

6432 (52.7)

1080 (53.7)

Anti-hypertensive drug prescription interval, n

12,150

2013

 1 month, n (%)

6812 (56.1)

1388 (69.0)

 2 months, n (%)

2251 (18.5)

302 (15.0)

 3 months, n (%)

2455 (20.2)

269 (13.4)

 6 months, n (%)

632 (5.2)

54 (2.7)

Blood pressure, n

11,906

2006

 Systolic blood pressure (Mean ± SD, mmHg)

129.2 ± 14.2

135.7 ± 17.9

 Diastolic blood pressure (Mean ± SD, mmHg)

78.6 ± 9.8

82.1 ± 11.5

Pulse rate (beats/min)

n (Mean ± SD)

11,440 (73.7 ± 10.4)

1954 (73.8 ± 10.1)

Duration of hypertension (Year)

n (Mean ± SD)

12,036 (7.0 ± 6.3)

1977 (7.0 ± 7.0)

Patients with Medical History, n (%)

3343 (27.3)

632 (31.2)

 Myocardial infarction, n (%)

408 (3.3)

64 (3.2)

 Heart Failure, n (%)

363 (3.0)

60 (3.0)

 Atrial Fibrillation, n (%)

337 (2.8)

86 (4.3)

 Stroke, n (%)

211 (1.7)

45 (2.2)

 Diabetes Mellitus, n (%)

2251 (18.38)

439 (21.7)

 Kidney Diseases, n (%)

197 (1.6)

30 (1.5)

  1. Data represents n (%) as categorical variables and Mean ± SD as continuous variables